Alleva
Anthony Alleva, Keansburg, NJ US
Patent application number | Description | Published |
---|---|---|
20120197810 | Selecting Packaging and Coolant Systems for Shipment of Biological Products - Disclosed is a process of selecting of a container and temperature-control system, such that biological products (including blood) requiring maintenance within a specified range of temperatures are so maintained during shipment. The process requires a prediction of the maximum period of shipment, and the predicted ambient temperature ranges and time of exposure thereto for the system during the period of shipment. With that information, a system of container(s) with temperature-control agents including dry ice, ice, frozen gel packs or a phase change material, is selected. | 08-02-2012 |
20120266564 | FABRICATING A FLEXIBLE RAPID BLOOD COOLING SYSTEM - A new blood unit cooling system was designed to cool blood rapidly to about 22° C. and maintain it at about that temperature, even in ambient temperature extremes, for several hours. The system incorporating a preferred eutectic solution including 98% -dodecanol, 1.5% myristyl alcohol and 0.5% 1-decanol (having, a melting point of about 23° C.) contained in a sealed flexible polymer layer, was used to cool whole blood-filled bags. The preferred design uses inner and outer containers, each made of transparent polyethylene sheets, where the inner compartments are filled with the solution and sealed, and then placed into each compartment in an outer container, wherein two compartments in the outer container are separated by a flattened and sealed portion of the polyethylene | 10-25-2012 |
20130255847 | FABRICATING A PHASE CHANGE BLOOD COOLING SYSTEM - A new blood unit cooling system was designed to cool blood rapidly to about 22° C. and maintain it at about that temperature, even in ambient temperature extremes, for several hours. The system incorporating a preferred eutectic solution including 98% 1-dodecanol 1.5% myristyl alcohol and 0.5% 1-decanol (having a melting point of about 23° C.) contained in a sealed flexible polymer layer, was used to cool whole blood-filled bags. The preferred design uses inner and outer containers, each made of transparent polyethylene sheets, where the inner compartments are filled with the solution and sealed, and then placed into each compartment in an outer container, wherein two compartments in the outer container are separated by a flattened and sealed portion of the polyethylene. | 10-03-2013 |
Carl J. Alleva, Simsbury, CT US
Patent application number | Description | Published |
---|---|---|
20090184522 | PERMANENT MAGNET ALTERNATOR SPEED DETECTION CIRCUIT WITH FEEDBACK AT LOWER SPEEDS - A permanent magnet alternator is driven by a turbine engine to supply three phases of power to a control circuit for the engine. A shunt regulator delivers current to the control circuit, and a voltage supply is also included to deliver power for a period of time as the alternator is gaining speed at startup. A speed detection circuit detects the speed of the shaft for diagnostic purposes and a feedback circuit overrides a control for the supply of the current at lower speeds such that the speed detection circuit will be accurate even at lower speeds. | 07-23-2009 |
David Alleva, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20080292640 | METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES - Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof. | 11-27-2008 |
20100303807 | METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES - Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof. | 12-02-2010 |
20110038859 | METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES - Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof. | 02-17-2011 |
David Alleva, Glastonbury, CT US
Patent application number | Description | Published |
---|---|---|
20150342210 | METABOLIC OIL COMPOSITION, SYSTEM AND METHOD OF USE - An oil composition product for use in providing improvement in the metabolic function of an individual. The oil composition product, system and method provides an oil blend with improved metabolic function to an individual's diet, a system and method monitoring of the individuals food intake with the food diary, and measuring the individuals metabolism with a metabolic analyzer integrated in the system. Changes in the individuals body composition are realized as the blend of oil composition product has the ability to increase a person's ability to burn more of their daily calories as fat, thereby increasing body fat loss and preserving lean muscle tissue, weight reduction and performance when part of a sensible diet and workout plan. | 12-03-2015 |
Fileno Alleva, Redmond, WA US
Patent application number | Description | Published |
---|---|---|
20140207448 | ADAPTIVE ONLINE FEATURE NORMALIZATION FOR SPEECH RECOGNITION - A speech recognition system adaptively estimates a warping factor used to reduce speaker variability. The warping factor is estimated using a small window (e.g. 100 ms) of speech. The warping factor is adaptively adjusted as more speech is obtained until the warping factor converges or a pre-defined maximum number of adaptation is reached. The speaker may be placed into a group selected from two or more groups based on characteristics that are associated with the speaker's window of speech. Different step sizes may be used within the different groups when estimating the warping factor. VTLN is applied to the speech input using the estimated warping factor. A linear transformation, including a bias term, may also be computed to assist in normalizing the speech along with the application of the VTLN. | 07-24-2014 |
Fileno A. Alleva, Redmond, WA US
Patent application number | Description | Published |
---|---|---|
20130304451 | BUILDING MULTI-LANGUAGE PROCESSES FROM EXISTING SINGLE-LANGUAGE PROCESSES - Processes capable of accepting linguistic input in one or more languages are generated by re-using existing linguistic components associated with a different anchor language, together with machine translation components that translate between the anchor language and the one or more languages. Linguistic input is directed to machine translation components that translate such input from its language into the anchor language. Those existing linguistic components are then utilized to initiate responsive processing and generate output. Optionally, the output is directed through the machine translation components. A language identifier can initially receive linguistic input and identify the language within which such linguistic input is provided to select an appropriate machine translation component. A hybrid process, comprising machine translation components and linguistic components associated with the anchor language, can also serve as an initiating construct from which a single language process is created over time. | 11-14-2013 |
Jennifer L. Alleva, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20130023676 | LIPHAGAL ENANTIOMERS AND THEIR DERIVATIVES AND PRECURSORS, AND ENANTIOSELECTIVE METHODS OF MAKING THE SAME - Enantioenriched compositions of liphagal and its derivatives and precursors include more than 50 mol % of a first enantiomer based on the total amount of a first and a second enantiomer. A method of making an enantioenriched composition includes catalytic enantioselective alkylation, ring expansion, and intramolecular aryne cyclization. | 01-24-2013 |